Skip to Content

Logo 5241 0.5 mg (Anagrelide 0.5 mg)

Pill imprint Logo 5241 0.5 mg has been identified as Anagrelide hydrochloride 0.5 mg.

Anagrelide is used in the treatment of thrombocythemia; chronic myelogenous leukemia and belongs to the drug class miscellaneous uncategorized agents. Risk cannot be ruled out during pregnancy. Anagrelide 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Anagrelide hydrochloride 0.5 mg Logo 5241 0.5 mg
Anagrelide hydrochloride 0.5 mg Logo 5241 0.5 mg
Anagrelide hydrochloride 0.5 mg Logo 5241 0.5 mg Front
Anagrelide hydrochloride 0.5 mg Logo 5241 0.5 mg Back
Anagrelide hydrochloride 0.5 mg Logo 5241 0.5 mg
Anagrelide hydrochloride
Imprint:
Logo 5241 0.5 mg
Strength:
0.5 mg
Color:
Gray / White
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous uncategorized agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00172-5241
Inactive Ingredients:
microcrystalline cellulose
crospovidone
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
aluminum oxide
ferrosoferric oxide
gelatin
lactose anhydrous
lactose monohydrate
magnesium stearate
povidone
propylene glycol
titanium dioxide
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5443 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide